auto_awesomeAI Summary
“Kintsugi, a seven-year-old startup developing AI to detect depression and anxiety from speech patterns, is closing due to inability to secure FDA clearance in time. The company is open-sourcing its technology, highlighting the significant regulatory hurdles AI health tools face and the challenges of commercializing medical AI applications.”
Depression-detecting AI startup Kintsugi shuts down after FDA clearance delays.
This summary was AI-generated. Neural Digest is not liable for the accuracy of source content. Read the original →
Read full article on The Verge AIopen_in_new